BPC 157: A MAHA Adjacent Peptide, Linked to Croatia Is BPC 157 Banned? Oral vs. Injectable Forms Explained BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest